All posts by Steve

2014 National Cancer Patient Experience Survey

Some links:

2014 National Cancer Patient Experience Survey website

2014 National Cancer Patient Experience Survey National Report

Individual hospital trust reports for our region that surveyed sarcoma patients:

The Royal Marsden NHS Foundation Trust

Royal National Orthopaedic Hospital NHS Trust

The surveys for Bournemouth and Southampton Hospitals didn’t include responses from sarcoma patients.

Importance of Clinical Nurse Specialists

The Nursing Times has published the following quotes from the 2014 National Cancer Patient Experience Survey

… there were also plenty of encouraging results, with more patients than ever (89%) reporting they had been given the name of a clinical nurse specialist (CNS) – up from 88% the previous year and 84% in 2010.

Ninety-one per cent said their CNS “definitely” listened carefully to them when they last spoke and that they got understandable answers to questions all or most of the time.

A key finding overall was the importance that patients placed on having access to a specialist nurse.

“At all cancers level, and for each of the 13 tumour groups, the results showed that the factor with the strongest association with high patient scores in the survey was always the presence of a clinical nurse specialist,” said the report on the survey results.

Follow-up paper

Clinical Oncology journal has published a paper titled

Comfort Blanket or Clinical Need? The Role of Follow-up for Cancer Survivors

detailing responses to a questionnaire devised by the Independent Cancer Patients’ Voice and National Cancer Research Institute Consumer Liaison Group last February.

Having completed the questionnaire, I wrote to Sarcoma UK saying that

Q16 There is increasing evidence to suggest that regular routine follow-up is of little benefit to some cancer patients. Many are now being discharged back to GPs after their primary treatment (eg surgery, radiotherapy and chemotherapy), but with rapid access to appropriate healthcare professional if/when needed.

is worrying and not applicable to sarcoma patients. In a very informative response, Sarcoma UK agreed with me saying that the questionnaire is more applicable to breast cancer patients and reassured me that it wasn’t applicable to sarcoma patients.

The paper has a section on GP follow-up and, whilst only 5% of patients had experience of this, nearly 50% say it isn’t a good model. This response

I can’t state strongly enough that I think this is not a good direction. General practitioners have little knowledge about cancer except the basics in my experience and it is frightening to think that this might be the way things go.

is precisely what I was thinking.

The paper is an interesting read and has no medical jargon so is easy to follow. A PDF download is available on the site which may be easier to read and print.

Cancer Research UK Statistics

Cancer Research UK has a vast array of statistics for all types of cancers at http://www.cancerresearchuk.org/cancer-info/cancerstats/

Sarcoma has two sections of its own

1.  Bone sarcoma statistics

    • 559 people in the UK were diagnosed with bone sarcoma in 2011.
    • There were 263 deaths from bone sarcoma in 2011.
    • 56% of adult bone sarcoma patients (58% of men and 54% of women) in England survived their cancer for five years or more in 2001-2005.

More detail can be found in Bone sarcoma statistics

2.  Soft tissue sarcoma statistics

    • 3,272 people in the UK were diagnosed with soft tissue sarcoma in 2010.
    • 56% of soft tissue sarcoma patients in England survived their cancer for five years or more in 2000-2004.

More detail can be found in Soft tissue sarcoma statistics

Sarcoma treatment guidelines

The Royal Marsden, treating soft-tissue sarcomas, and University College Hospital and Royal National Orthopaedic Hospital, treating both bone and soft-tissue sarcomas [1], form the London and South East Sarcoma Network. They have recently published detailed guidelines for treatment and follow-up procedures.

They show what should happen, in detail, for each sarcoma subtype and these guidelines are worth reading.

This will give you the information you need to see how your treatment should progress in any hospital, not just the three author hospitals.

The guidelines can be downloaded at http://www.lsesn.nhs.uk/guidelines.html.

[1] Description taken from London and South East Sarcoma Network home page.

Facts for my GP

Some of the things I will be telling my GP to go with the On The Ball pack:

  • Sarcoma UK are worried that recognition of sarcoma is not as good as it could be. This is because sarcoma is so rare (less than 1% of all cancers in England) and sometimes quite difficult to diagnose. Unfortunately the survival rate is only 55% and the aim is to dramatically increase that.
  • A recent report from Cancer52  on National Cancer Intelligence Network data shows that the survival rate for soft tissue sarcoma is 98% if the GP refers a patient within a month.
  • Statistically speaking, a GP is not likely to see more than one patient with sarcoma in their career lifetime making diagnosis that much more difficult.